Login
$ONC
$411.29 -$5.25 (1.26%) Live

Ownership

13F as of Q2 2026 · 1.48B shares outstanding

Who owns ONC?

By type of holder
Institutions 2.4% Insiders 0.0% Everyone else 97.6%
Concentration Top 10 holders own 29.8%
Felix J. Baker 7.8% · Julian C. Baker 7.8%
Institutional ownership
2.4%
0.0 pts vs last qtr
Institutional holders
284
+1 vs last qtr
Net shares bought
+147.3K
by institutions in Q2 2026
New / sold out
46 / 45
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Capital World Investors +626.9K
  • Citadel Advisors LLC +393.2K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • FMR LLC −1.2M
  • HHLR Advisors, LTD. SOLD OUT −1.0M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$398M
41 notices from 15 people
Shares covered
1.2M
0.08% of the company
Arranged in advance
98%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$108.8M$217.5MDec 2025: $31.9M under a 10b5-1 planDecJanFeb 2026: $1.6M under a 10b5-1 planFebMarAprMay 2026: $418.4K under a 10b5-1 planMay 2026: $327.9K without a planMayJun 2026: $7.3M without a planJunJul 2026: $217.2M under a 10b5-1 planJul 2026: $337.9K without a planJulAug 2026: $90.2M under a 10b5-1 planAug 2026: $1.2M without a planAugSep 2026: $47.5M under a 10b5-1 planSep 2026: $47.0K without a planSepOctNov
Largest proposed sellers
  • John V Oyler Director 10b5-1 $317M
  • Xiaodong Wang Director 10b5-1 $47.1M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+265.4%
+15.49% a year
Each share's claim on the business
−72.6%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $2.32B
over 10 fiscal years
Diluted shares, split-adjusted
391.5M940.5M1.49B2016: 403.6M shares'162017: 543.2M shares'172018: 720.8M shares'182019: 780.7M shares'192020: 1.09B shares'202021: 1.21B shares'212022: 1.34B shares'222023: 1.36B shares'232024: 1.37B shares'242025: 1.47B shares'25
Buybacks Stock-based comp
$0$255.4M$510.9M2016 buybacks: $02016 stock comp: $10.6M'162017 buybacks: $02017 stock comp: $42.9M'172018 buybacks: $02018 stock comp: $87.1M'182019 buybacks: $02019 stock comp: $134.2M'192020 buybacks: $02020 stock comp: $183.5M'202021 buybacks: $02021 stock comp: $240.7M'212022 buybacks: $02022 stock comp: $303.2M'222023 buybacks: $02023 stock comp: $367.6M'232024 buybacks: $02024 stock comp: $441.6M'242025 buybacks: $02025 stock comp: $510.9M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years79% 3–5 years2% 1–3 years8% Under 1 year10%
Quarterly turnover
9.1%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting ONC on Form 13F
BB
Baker Bros. Advisors LP
13D · 7.8%
Shares
8.8M
% of company
0.60%
Change vs last qtr
+2.5K (+0.0%)
Held since
≤2021
PM
Primecap Management Co/ca/
Shares
5.0M
% of company
0.34%
Change vs last qtr
+32.8K (+0.7%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding BeOne Medicines Ltd., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting ONC on Form N-PORT; together they hold 0.8% of the company
NP
New Perspective Fund
Position value
$759M
% of company
0.18%
% of the fund
0.45%
As of
June 30, 2026
NE
New Economy Fund
Position value
$315M
% of company
0.06%
% of the fund
0.63%
As of
August 31, 2026

23 more funds behind a free account

See every fund holding BeOne Medicines Ltd. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
FJ
Felix J. Baker
5%+ holder13D · 7.8%
Shares
115.9M
% of company
7.84%
Change vs last qtr
—
Held since
—
JC
Julian C. Baker
5%+ holder13D · 7.8%
Shares
115.9M
% of company
7.84%
Change vs last qtr
—
Held since
—

3 more holders behind a free account

See every insider and 5%+ holder of BeOne Medicines Ltd..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support